Chronic morphine treatment inhibits oxytocin synthesis in rats

被引:42
作者
You, ZD [1 ]
Li, JH [1 ]
Song, CY [1 ]
Wang, CH [1 ]
Lu, CL [1 ]
机构
[1] Second Mil Med Univ, Dept Neurobiol, Shanghai 200433, Peoples R China
关键词
in situ hybridization; micropunch; morphine dependence; naloxone; oxytocin; radioimmunoassay; rats; supraoptic nucleus;
D O I
10.1097/00001756-200009280-00015
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The changes of oxytocin content and mRNA expression in some nuclei were investigated in morphine-dependent rats using radioimmunoassay (RIA) and in situ hybridization (ISH). After chronic administration of morphine, the oxytocin content in supraoptic nucleus (SON) and nucleus accumbens (NAc) decreased, and increased in the ventral tegment area (VTA) and locus coeruleus (LC), but did not change in other nuclei including the paraventricular nucleus (PVN), lateral septum (SEPTUM), raphe magnus nucleus (NRM) and periaquaductal gray (PAG). In morphine-L dependent rats, naloxone increased the levels of oxytocin in SON and PVN, but decreased that in LC. ISH first showed that chronic morphine treatment inhibited the oxytocin synthesis in SON but not in PVN. The present study demonstrates that chronic morphine treatment alters the brain oxytocin system, suggesting that oxytocin might contribute to the behavioral and neuroendocrine responses to morphine. NeuroReport 11:3113-3116 (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:3113 / 3116
页数:4
相关论文
共 30 条
[1]   CONTRASTING ACTIONS OF AMINO-ACIDS, ACETYLCHOLINE, NORADRENALINE AND LEUCINE ENKEPHALIN ON THE EXCITABILITY OF SUPRAOPTIC VASOPRESSIN-SECRETING NEURONS - A MICROIONTOPHORETIC STUDY IN THE RAT [J].
ARNAULD, E ;
CIRINO, M ;
LAYTON, BS ;
RENAUD, LP .
NEUROENDOCRINOLOGY, 1983, 36 (03) :187-196
[2]  
BAO XM, 1991, BEIJING
[3]   NALOXONE EXCITES OXYTOCIN NEURONS IN THE SUPRAOPTIC NUCLEUS OF LACTATING RATS AFTER CHRONIC MORPHINE TREATMENT [J].
BICKNELL, RJ ;
LENG, G ;
LINCOLN, DW ;
RUSSELL, JA .
JOURNAL OF PHYSIOLOGY-LONDON, 1988, 396 :297-317
[4]   OPIATE INHIBITION OF PEPTIDE RELEASE FROM THE NEUROHUMORAL TERMINALS OF HYPOTHALAMIC NEURONS [J].
CLARKE, G ;
WOOD, P ;
MERRICK, L ;
LINCOLN, DW .
NATURE, 1979, 282 (5740) :746-748
[5]  
COLLIER HOJ, 1984, OPIOIDS PAST PRESENT, P109
[6]   DIFFERENTIAL MODIFICATION OF MORPHINE AND METHADONE DEPENDENCE BY INTERFERON-ALPHA [J].
DOUGHERTY, PM ;
PEARL, J ;
KRAJEWSKI, KJ ;
PELLIS, NR ;
DAFNY, N .
NEUROPHARMACOLOGY, 1987, 26 (11) :1595-1600
[7]  
HALDAR J, 1978, P SOC EXP BIOL MED, V157, P476, DOI 10.3181/00379727-157-40080
[8]   KAPPA-SELECTIVE AGONISTS DECREASE POSTSYNAPTIC POTENTIALS AND CALCIUM COMPONENTS OF ACTION-POTENTIALS IN THE SUPRAOPTIC NUCLEUS OF RAT HYPOTHALAMUS IN-VITRO [J].
INENAGA, K ;
NAGATOMO, T ;
NAKAO, K ;
YANAIHARA, N ;
YAMASHITA, H .
NEUROSCIENCE, 1994, 58 (02) :331-340
[9]   KAPPA-SELECTIVE OPIOID RECEPTOR AGONISTS LEUMORPHIN AND DYNORPHIN INHIBIT SUPRAOPTIC NEURONS IN RAT HYPOTHALAMIC SLICE PREPARATIONS [J].
INENAGA, K ;
IMURA, H ;
YANAIHARA, N ;
YAMASHITA, H .
JOURNAL OF NEUROENDOCRINOLOGY, 1990, 2 (03) :389-395
[10]  
KOVACS GL, 1987, FRONT HORM RES, V15, P138